Cost-effectiveness of Future Biomarkers for Colorectal Cancer Screening: Quantified Futility or Call for Innovation?

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)483-485
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Medical Futility
Early Detection of Cancer
Cost-Benefit Analysis
Colorectal Neoplasms
Biomarkers

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

@article{75e3367e56bc46a592d7c6326637a1d5,
title = "Cost-effectiveness of Future Biomarkers for Colorectal Cancer Screening: Quantified Futility or Call for Innovation?",
author = "Thomas Imperiale and Charles Kahi",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.cgh.2017.12.025",
language = "English (US)",
volume = "16",
pages = "483--485",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Cost-effectiveness of Future Biomarkers for Colorectal Cancer Screening

T2 - Quantified Futility or Call for Innovation?

AU - Imperiale, Thomas

AU - Kahi, Charles

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85043983122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043983122&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2017.12.025

DO - 10.1016/j.cgh.2017.12.025

M3 - Editorial

C2 - 29277618

AN - SCOPUS:85043983122

VL - 16

SP - 483

EP - 485

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 4

ER -